Swamy model lie exposed: Ministry says Priyanka, Karti have only one DIN

India on Sunday witnessed annual solar eclipse or 'surya grahan' 2020, the third eclipse even for this year after first two lunar eclipses took place in January and June and the last annual solar eclipse of this decade.

The solar eclipse started from around 9 a.m. across the Indian map as the Sun, the Moon, and the Earth came in a straight line, and the country witnessed the 'deepest' annular solar eclipse in over a century.

Astrologers said it a fourth super rare hybrid eclipse which is a mix between an annular and total solar eclipse.

Areas like Hyderabad, Chennai, Bhubaneshwar, Kolkata, Lucknow, Mumbai, Delhi, Patna, Shillong and more witnessed a partial phase of the annular solar eclipse from 9 a.m.

In the eclipse, the distance of the Moon and Earth will be larger than usual which means the moon will not be able to cover up the sun fully and will leave out the borders of the sun - giving an appearance of a "Ring of Fire".

Press Information Bureau in a tweet informed that it is the last annular solar eclipse in India of this decade.

People can catch glimpse of the partially covered sun between 10 a.m. and 2.28 p.m. as per the time differing as locations in India. The eclipse will continue for over three hours covering 84 per cent Sun.

There are three types of solar eclipses - total, partial, and annular.

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.

Bengaluru, Jul 10: Karnataka health minister B Sriramulu on Thursday said that the government is planning to increase number of COVID-19 testing labs and technicians in the state.

Speaking to news agency, Sriramulu said, "We have 72 labs where COVID-19 tests are conducted. They are under pressure with increased number of tests. When lab technicians are quarantined, it gets difficult to complete work. So we are considering to increase number of labs and technicians."

Speaking on the community transmission of COVID-19 in Bengaluru, he said, "The experts are already deliberating over the issue of community transmission. According to me the community spread has not taken place yet."

Meanwhile, Cabinet Minister Madhu Swamy said that the government is calling for foreign investment for which Boston Consulting Group (BCG) has been hired by the state government.

Speaking to the reporters after the Cabinet meeting, Swamy said, "We call for foreign investment in Karnataka for which we need an agency who has to coordinate, who has to bring outsiders in Karnataka to invest in the state. For that we have hired a company by name Boston consulting Group(BCG) we will be paying them Rs 1 crore for twelve months."